Stimulation of mutagenesis by proportional deoxyribonucleoside triphosphate accumulation in Escherichia coli.
Intracellular pool sizes of deoxyribonucleoside triphosphates (dNTPs) are highly regulated. Unbalanced dNTP pools, created by abnormal accumulation or deficiency of one nucleotide, are known to be mutagenic and to have other genotoxic consequences. Recent studies in our laboratory on DNA replication in vitro suggested that balanced accumulation of dNTPs, in which all four pools increase proportionately, also stimulates mutagenesis. In this paper, we ask whether proportional dNTP pool increases are mutagenic also in living cells. Escherichia coli was transformed with recombinant plasmids that overexpress E. coli genes nrdA and nrdB, which encode the two protein subunits of aerobic ribonucleotide reductase. Roughly proportional dNTP pool expansion, by factors of 2- to 6-fold in different experiments, was accompanied by increases in spontaneous mutation frequency of up to 40-fold. Expression of a catalytically inactive ribonucleotide reductase had no effect on either dNTP pools or mutagenesis, suggesting that accumulation of dNTPs is responsible for the increased mutagenesis. Preliminary experiments with strains defective in SOS regulon induction suggest a requirement for one or more SOS functions in the dNTP-enhanced mutagenesis. Because a replisome extending from correctly matched 3'-terminal nucleotides is almost certainly saturated with dNTP substrates in vivo, whereas chain extension from mismatched nucleotides almost certainly proceeds at sub-saturating rates, we propose that the mutagenic effect of proportional dNTP pool expansion is preferential stimulation of chain extension from mismatches as a result of increases in intracellular dNTP concentrations.
Wheeler
Linda J
LJ
Department of Biochemistry and Biophysics, Oregon State University, Corvallis, 97331-7305, USA.
Rajagopal
Indira
I
Mathews
Christopher K
CK
D001426:Bacterial Proteins / Q000235:genetics; D020137:Base Pair Mismatch; D003523:Cycloserine / Q000494:pharmacology; D004261:DNA Replication; D004259:DNA-Directed DNA Polymerase / Q000378:metabolism; D003854:Deoxyribonucleotides / Q000378:metabolism*; D004926:Escherichia coli / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism*; D007700:Kinetics; D016296:Mutagenesis / Q000187:drug effects; D009154:Mutation / Q000235:genetics; D012264:Ribonucleotide Reductases / Q000235:genetics / Q000378:metabolism; D013014:SOS Response, Genetics; D012697:Serine Endopeptidases / Q000235:genetics; D000099160:LexA Repressor Protein
D001426:Bacterial Proteins; D003523:Cycloserine; D004259:DNA-Directed DNA Polymerase; D003854:Deoxyribonucleotides; D012264:Ribonucleotide Reductases; D012697:Serine Endopeptidases; D000099160:LexA Repressor Protein